Yale researchers have identified a drinkable cocktail of designer molecules that interferes with a crucial first step of Alzheimer’s and even restores memories in mice, they report Jan. 2 in the journal Cell Reports.
The binding of amyloid beta peptides...
In response to the rapidly escalating opioid crisis, the Yale University Department of Emergency Medicine (DEM) joined forces with Yale New Haven Health System (YNHHS) to expand Project ASSERT (Alcohol & Substance Abuse Services, Education, &...
By measuring the strength of connections between different brain networks, Yale researchers successfully predicted who would abstain from cocaine during treatment, they report Jan. 4 in the American Journal of Psychiatry.
The machine-learning technique...
One of four patients admitted to hospitals for evaluation of seizures don’t have epilepsy but rather have a debilitating and difficult to diagnose condition known as psychogenic non-epileptic seizures, or PNES.
Nearly 80 percent of these patients who...
Taking prescribed opioids raises the risk of pneumonia in individuals with and without HIV, a new Yale-led study finds.
The study, published in JAMA Internal Medicine, reinforces the concern that prescription opioid painkillers have a negative impact on...
Research from the World Health Organization (WHO) has found that more than 500 million people worldwide suffer from mental health disorders, costing the global economy more than $1 trillion in U.S. dollars annually in lost productivity. Of those people, a...